TG100801

· TargeGen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TG100801, covering 2010-03-29 to 2010-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD [Phase 2]